Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
European Research Journal ; 9(3):536-542, 2023.
Article in English | Academic Search Complete | ID: covidwho-2301526

ABSTRACT

Objectives: In this study, besides the factors affecting breastfeeding, such as the tendency to breastfeed, the number of children, educational status, maternal age, working style, it was investigated how the breastfeeding behavior was affected during the epidemic. Methods: At least 384 mothers were included in the study with a 95% confidence level, 0.05 margin of error, and 403 mothers were included in the study. A questionnaire form prepared by the researchers was used as a data collection tool and consent form was obtained from the participants. Results: The mean age of the mothers participating in the study was 29.2 ± 5.9 years (range:18 to 52 years). Two hundred and one (49.8%) mothers participating in the study do not find it safe for mothers with COVID-19 to breastfeed their baby. However, only 20.2% of mothers think that COVID-19 can be transmitted to the baby through breast milk. Ninety-eight (24.4%) mothers stated that they could breastfeed their babies even if they had COVID-19, and 15.5% stated that mothers with COVID-19 around them could breastfeed their babies. Conclusions: Although the COVID-19 epidemic had a negative impact on all aspects of life globally, it did not generally change the breastfeeding decisions of breastfeeding mothers. In fact, due to the closures and extended maternity leave, mothers spent more time with their babies and enabled them to breastfeed more frequently. However, it should not be neglected that misinformation is at a substantial level. In the studies conducted, wrong or incomplete information was observed in a significant part of the mothers who did not consider breastfeeding due to the epidemic, although the rates were low. For this reason, besides health professionals, media organs should be actively used for information. [ FROM AUTHOR] Copyright of European Research Journal is the property of Prusa Medical Publishing and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)

2.
Vaccines (Basel) ; 11(4)2023 Apr 07.
Article in English | MEDLINE | ID: covidwho-2301527

ABSTRACT

We aimed to determine the attitudes and behaviors of breastfeeding mothers regarding the vaccine by examining their knowledge of the COVID-19 virus vaccine and their hesitations about it. The research is a cross-sectional and descriptive study conducted in the Kahta district of Adiyaman, a southeastern province in Turkey, between January and May 2022. The study population consisted of 405 mothers who applied to the Kahta State Hospital Pediatrics outpatient clinic. A questionnaire form was used as a data collection tool, and a consent form was obtained from the participants. The vaccination rate (89%) of those who graduated from high school and above was significantly higher than that of those who graduated from secondary school or below (77.7%). As the economic situation worsened, the vaccination rate decreased. The vaccination rate (85.7%) of mothers whose breastfed child was 0-6 months old was found to be significantly higher than that of those with 7-24-month-olds (76.4%) (p:0.02). The rate of being vaccinated (73.3%) of those who had a new type of COVID-19 virus infection was significantly lower than the rate of being vaccinated (86.3%) of those who did not have a COVID-19 virus infection. The vaccination rate of those who received information from their family doctor and the internet was higher than that of those who received information from radio/TV and people around. The rate of mothers thinking babies should stop breastfeeding who graduated from secondary school or below was higher (53.2%) than the rate of mothers who graduated from high school or above (30.2%) to be vaccinated against the COVID-19 virus. To eliminate the hesitancy about vaccination in mothers, it is necessary to inform and educate the whole society correctly, starting with families with low education and economic levels.

3.
Respir Med Res ; 81: 100900, 2022 May.
Article in English | MEDLINE | ID: covidwho-1712958

ABSTRACT

BACKGROUND: There are few data on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19) infection in patients with idiopathic pulmonary fibrosis (IPF). The objective of this study is to describe the characteristics and outcomes of IPF patients confirmed COVID-19 infection. METHODS: In this retrospective, multi-center, cohort study, patients from 4 hospital medical records with known IPF and a COVID-19 diagnosis were identified. Demographic and clinical outcome data were abstracted through a review of electronic medical records. RESULTS: Records for 46 patients with IPF and COVID-19 were abstracted. The mean age was 65±10 years. The most common symptom was dyspnea, followed by fever and cough. Ground-glass opacities (n = 35, 83.3%) and consolidations (n = 11, 26.1%) were the main imaging features of the disease in thorax computed tomography (CT). Twenty-four patients (52.1%) required hospitalization. Among the hospitalized patients, 16 (66.6%) were admitted to the intensive care unit (ICU), and 10 (41.6%) underwent invasive mechanical ventilation. Thirteen patients (28.2%) died of COVID-19 complications. Mortality rate was significantly associated with lower DLCO/VA, long term oxygen therapy and consolidation finding on CT of thorax (p<0.05). On multivariable analysis, neither factor was associated with hospitalization or mortality. CONCLUSIONS: IPF patients represent a vulnerable population for COVID-19, according to the high rate of hospitalization, ICU requirement, and mortality rate. Measures to minimize the risk of COVID-19 infection remain key to protect IPF patients.


Subject(s)
COVID-19 , Idiopathic Pulmonary Fibrosis , Aged , COVID-19/complications , COVID-19/epidemiology , COVID-19/therapy , COVID-19 Testing , Cohort Studies , Humans , Idiopathic Pulmonary Fibrosis/diagnosis , Idiopathic Pulmonary Fibrosis/epidemiology , Idiopathic Pulmonary Fibrosis/therapy , Middle Aged , Multicenter Studies as Topic , Retrospective Studies , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL